J1306 HCPCS code: Injection, inclisiran, 1 mg
J1306 is the HCPCS Level II code for injection, inclisiran, 1 mg. In 2024 Medicare paid an average of $9.47 per service for J1306 across 15,517,210 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 284 per day on outpatient hospital claims. Medicare volume rose 754% from 2022 to 2024 (1,816,103 to 15,517,210 services). In 2024, about 3,381 clinicians billed Medicare for J1306 for 30,308 beneficiaries; California, Florida, Texas accounted for 35% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-07-01 |
| Last action effective | 2022-07-01 |
Who bills J1306 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,381 |
| Medicare beneficiaries | 30,308 |
| States with claims | 47 |
| Share of services in top 3 states (California, Florida, Texas) | 35% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J1306, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 1,816,103 | 5,091 | $11.79 | $9.40 |
| 2023 | 8,252,314 | 16,905 | $11.78 | $9.36 |
| 2024 | 15,517,210 | 30,308 | $11.93 | $9.47 |
States with the most J1306 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| California | 2,050,213 | $9.49 |
| Florida | 1,711,863 | $9.49 |
| Texas | 1,636,661 | $9.46 |
| Arizona | 767,813 | $9.49 |
| Georgia | 759,326 | $9.47 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 284 | Prescribing Information |
| practitioner claims | 284 | Prescribing Information |
What changed for J1306
- 2022-07-01: J1306 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J1306?
J1306 is the HCPCS Level II code for injection, inclisiran, 1 mg. Short descriptor: "Injection, inclisiran, 1 mg".
How much does Medicare pay for J1306?
In 2024, the average Medicare payment was $9.47 per service (average allowed $11.93).
Does Medicare cover J1306?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J1306 can be billed per day?
284 on outpatient hospital claims; 284 on practitioner claims (NCCI medically unlikely edits).
Related J13 codes
- J1300 — Injection, eculizumab, 10 mg
- J1301 — Injection, edaravone, 1 mg
- J1302 — Injection, sutimlimab-jome, 10 mg
- J1303 — Injection, ravulizumab-cwvz, 10 mg
- J1304 — Injection, tofersen, 1 mg
- J1305 — Injection, evinacumab-dgnb, 5mg
- J1307 — Injection, crovalimab-akkz, 10 mg
- J1308 — Injection, famotidine, 0.25 mg
- J1320 — Injection, amitriptyline hcl, up to 20 mg
- J1322 — Injection, elosulfase alfa, 1 mg
- J1323 — Injection, elranatamab-bcmm, 1 mg
- J1324 — Injection, enfuvirtide, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J1306
- Watch J1306 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J1306
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.